Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once daily inhalation as a fixed-dose combination in healthy subjects
H. Tillmann (Basel, Switzerland), B. Ethell (Cambridge, United States of America), N. Abdallah (Basel, Switzerland), S. Machineni (Hyderabad, India), A. Drollmann (Basel, Switzerland), S. Last (Berlin, Germany), M. Hahn (Basel, Switzerland), R. Radhakrishnan (Hyderabad, India), S. Ignatenko (Berlin, Germany), S. Vaidya (Cambridge, United States of America)
Source: International Congress 2019 – Clinical studies of asthma treatments
Session: Clinical studies of asthma treatments
Session type: Thematic Poster
Number: 2540
Disease area: Airway diseases
Rating: 
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Tillmann (Basel, Switzerland), B. Ethell (Cambridge, United States of America), N. Abdallah (Basel, Switzerland), S. Machineni (Hyderabad, India), A. Drollmann (Basel, Switzerland), S. Last (Berlin, Germany), M. Hahn (Basel, Switzerland), R. Radhakrishnan (Hyderabad, India), S. Ignatenko (Berlin, Germany), S. Vaidya (Cambridge, United States of America). Pharmacokinetics of indacaterol, glycopyrronium and mometasone furoate following once daily inhalation as a fixed-dose combination in healthy subjects. 2540
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you: